日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Differentiating benign and malignant solitary pulmonary nodules through exhaled breath analysis

通过呼出气体分析鉴别良性和恶性孤立性肺结节

Zwijsen, Kathleen; Wener, Reinier R L; Heirwegh, Ellen; van Meerbeeck, Jan P; Schillebeeckx, Eline; Raskin, Jo; Marcq, Elly; Van Schil, Paul E; Snoeckx, Annemiek; Janssens, Annelies; Lamote, Kevin

Co-targeting of VEGFR2 and PD-L1 promotes survival and vasculature normalization in pleural mesothelioma.

联合靶向 VEGFR2 和 PD-L1 可促进胸膜间皮瘤患者的生存和血管正常化

Rovers Sophie, Van Audenaerde Jonas, Verloy Ruben, De Waele Jorrit, Brants Louize, Hermans Christophe, Lau Ho Wa, Merlin Céline, Möller Ribas Maria, Ponsaerts Peter, Van Laere Steven, Lardon Filip, Wouters An, Fisher Scott A, van Meerbeeck Jan, Marcq Elly, Smits Evelien

A Minimally Invasive Transthoracic Injection Technique for Reproducible Intrapleural Delivery in Mice

一种用于小鼠可重复胸膜内给药的微创经胸注射技术

Rovers, Sophie; Farahmand, Pooyeh; Liu, Dana; Brants, Louize; Hermans, Christophe; Peeters, Dieter; McKinven, Danielle; Doig, Jennifer; Lardon, Filip; van Meerbeeck, Jan; Marcq, Elly; Murphy, Daniel J; Smits, Evelien

Anti-metabolite chemotherapy increases LAG-3 expressing tumor-infiltrating lymphocytes which can be targeted by combination immune checkpoint blockade

抗代谢化疗会增加表达LAG-3的肿瘤浸润淋巴细胞,这些细胞可作为联合免疫检查点阻断疗法的靶点。

Principe, Nicola; Phung, Amber-Lee; Stevens, Kofi L P; Elaskalani, Omar; Wylie, Ben; Tilsed, Caitlin M; Sheikh, Fezaan; Orozco Morales, M Lizeth; Kidman, Joel; Marcq, Elly; Fisher, Scott A; Nowak, Anna K; McDonnell, Alison M; Lesterhuis, W Joost; Chee, Jonathan

The MexTAg collaborative cross: host genetics affects asbestos related disease latency, but has little influence once tumours develop

MexTAg合作研究发现:宿主遗传因素会影响石棉相关疾病的潜伏期,但对肿瘤发展后的影响甚微。

Fisher, Scott A; Patrick, Kimberley; Hoang, Tracy; Marcq, Elly; Behrouzfar, Kiarash; Young, Sylvia; Miller, Timothy J; Robinson, Bruce W S; Bueno, Raphael; Nowak, Anna K; Lesterhuis, W Joost; Morahan, Grant; Lake, Richard A

Optimization of the Solvent and In Vivo Administration Route of Auranofin in a Syngeneic Non-Small Cell Lung Cancer and Glioblastoma Mouse Model

在同源非小细胞肺癌和胶质母细胞瘤小鼠模型中优化奥拉诺芬的溶剂和体内给药途径

Freire Boullosa, Laurie; Van Loenhout, Jinthe; Hermans, Christophe; Lau, Ho Wa; Merlin, Céline; Marcq, Elly; Takhsha, Farnaz Sedigheh; Martinet, Wim; De Meyer, Guido R Y; Lardon, Filip; Smits, Evelien L J; Deben, Christophe

External Validation of a Breath-Based Prediction Model for Malignant Pleural Mesothelioma

基于呼吸的恶性胸膜间皮瘤预测模型的外部验证

Janssens, Eline; Schillebeeckx, Eline; Zwijsen, Kathleen; Raskin, Jo; Van Cleemput, Joris; Surmont, Veerle F; Nackaerts, Kristiaan; Marcq, Elly; van Meerbeeck, Jan P; Lamote, Kevin

Recent Advances of Immune Checkpoint Inhibition and Potential for (Combined) TIGIT Blockade as a New Strategy for Malignant Pleural Mesothelioma

免疫检查点抑制剂的最新进展及(联合)TIGIT阻断作为恶性胸膜间皮瘤新策略的潜力

Rovers, Sophie; Janssens, Annelies; Raskin, Jo; Pauwels, Patrick; van Meerbeeck, Jan P; Smits, Evelien; Marcq, Elly

Headspace Volatile Organic Compound Profiling of Pleural Mesothelioma and Lung Cancer Cell Lines as Translational Bridge for Breath Research

胸膜间皮瘤和肺癌细胞系顶空挥发性有机化合物分析作为呼吸研究的转化桥梁

Janssens, Eline; Mol, Zoë; Vandermeersch, Lore; Lagniau, Sabrina; Vermaelen, Karim Y; van Meerbeeck, Jan P; Walgraeve, Christophe; Marcq, Elly; Lamote, Kevin

Immune Checkpoint Inhibitory Therapy in Sarcomas: Is There Light at the End of the Tunnel?

肉瘤的免疫检查点抑制疗法:曙光就在前方吗?

Siozopoulou, Vasiliki; Domen, Andreas; Zwaenepoel, Karen; Van Beeck, Annelies; Smits, Evelien; Pauwels, Patrick; Marcq, Elly